Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Effect of an Electronic Health Record Decision Support Alert to Decrease Excess Cervical Cancer Screening.

Teoh D, Vogel RI, Langer A, Bharucha J, Geller MA, Harwood E, Kulasingam S, Melton GB.

J Low Genit Tract Dis. 2019 Oct;23(4):253-258. doi: 10.1097/LGT.0000000000000484.

PMID:
31592972
2.

Semiquantitative assessment of cytomorphologic features can predict mutation status of thyroid nodules with indeterminate cytologic diagnosis.

Shahi M, Bloechl SJ, Vogel RI, Shrestha R, Krigman HR, Evasovich M, Burmeister LA, Amin K.

Hum Pathol. 2019 Aug 19;93:81-89. doi: 10.1016/j.humpath.2019.08.010. [Epub ahead of print]

PMID:
31437520
3.

Breast Cancer Screening Practices for High-Risk Women: A Cross-Sectional Survey of Primary Care Providers.

Blaes A, Vogel RI, Nagler RH, Allen A, Mason S, Teoh D, Talley K, Raymond NC, Wyman JF.

J Womens Health (Larchmt). 2019 Aug 21. doi: 10.1089/jwh.2018.7463. [Epub ahead of print]

PMID:
31433260
4.

Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study.

Lou E, Vogel RI, Hoostal S, Wong P, Grad A, Monu M, Łukaszewski T, Deshpande J, Dickson EL, Klein M, Linden MA, Subramanian S, Teoh D, Geller MA.

Oncologist. 2019 Nov;24(11):1422-e1013. doi: 10.1634/theoncologist.2019-0497. Epub 2019 Jul 25.

PMID:
31346130
5.

Mammography Screening Practices in Average-Risk Women Aged 40-49 Years in Primary Care: A Comparison of Physician and Nonphysician Providers in Minnesota.

Martin K, Vogel RI, Nagler RH, Wyman JF, Raymond N, Teoh D, Allen AM, Talley KMC, Mason S, Blaes AH.

J Womens Health (Larchmt). 2019 Jul 16. doi: 10.1089/jwh.2018.7436. [Epub ahead of print]

PMID:
31314684
6.

Tumor-Stroma Proportion as a Predictive Biomarker of Resistance to Platinum-Based Chemotherapy in Patients With Ovarian Cancer.

Lou E, Vogel RI, Hoostal S, Klein M, Linden MA, Teoh D, Geller MA.

JAMA Oncol. 2019 Jun 1. doi: 10.1001/jamaoncol.2019.1943. [Epub ahead of print] No abstract available.

PMID:
31152668
7.

JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors.

Irey EA, Lassiter CM, Brady NJ, Chuntova P, Wang Y, Knutson TP, Henzler C, Chaffee TS, Vogel RI, Nelson AC, Farrar MA, Schwertfeger KL.

Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12442-12451. doi: 10.1073/pnas.1816410116. Epub 2019 May 30.

PMID:
31147469
8.

CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells.

Ahmed RL, Shaughnessy DP, Knutson TP, Vogel RI, Ahmed K, Kren BT, Trembley JH.

Pharmaceuticals (Basel). 2019 Apr 2;12(2). pii: E50. doi: 10.3390/ph12020050.

9.

Patient satisfaction with patient-provider interactions at time of diagnosis among early stage melanoma survivors: A cross-sectional survey.

Zaffran K, Lazovich D, Boull C, Vogel RI.

J Am Acad Dermatol. 2019 Nov;81(5):1207-1209. doi: 10.1016/j.jaad.2019.04.014. Epub 2019 Apr 12. No abstract available.

PMID:
30986476
10.

Sexual quality of life after the treatment of gynecologic cancer: what women want.

Hubbs JL, Dickson Michelson EL, Vogel RI, Rivard CL, Teoh DGK, Geller MA.

Support Care Cancer. 2019 Dec;27(12):4649-4654. doi: 10.1007/s00520-019-04756-7. Epub 2019 Apr 2.

PMID:
30941579
11.

The American College of Surgeon's surgical risk calculator's ability to predict disposition in older gynecologic oncology patients undergoing laparotomy.

Shaker S, Rivard C, Nahum R, Vogel RI, Teoh D.

J Geriatr Oncol. 2019 Jul;10(4):618-622. doi: 10.1016/j.jgo.2019.02.008. Epub 2019 Feb 23.

PMID:
30803821
12.

Evaluation of graphic messages to promote human papillomavirus vaccination among young adults: A statewide cross-sectional survey.

Teoh D, Shaikh R, Schnaith A, Lou E, McRee AL, Nagler RH, Vogel RI.

Prev Med Rep. 2019 Jan 11;13:256-261. doi: 10.1016/j.pmedr.2019.01.002. eCollection 2019 Mar.

13.

A patient-centered mobile health application to motivate use of genetic counseling among women with ovarian cancer: A pilot randomized controlled trial.

Vogel RI, Niendorf K, Petzel S, Lee H, Teoh D, Blaes AH, Argenta P, Rivard C, Winterhoff B, Lee HY, Geller MA.

Gynecol Oncol. 2019 Apr;153(1):100-107. doi: 10.1016/j.ygyno.2019.01.019. Epub 2019 Feb 1.

PMID:
30718125
14.

Development of a multiplexed giant magnetoresistive biosensor array prototype to quantify ovarian cancer biomarkers.

Klein T, Wang W, Yu L, Wu K, Boylan KLM, Vogel RI, Skubitz APN, Wang JP.

Biosens Bioelectron. 2019 Feb 1;126:301-307. doi: 10.1016/j.bios.2018.10.046. Epub 2018 Oct 23.

PMID:
30445305
15.

Arterial elasticity as a risk factor for early cardiovascular disease among testicular cancer survivors treated with platinum-based chemotherapy: a cross-sectional pilot study.

Blaes AH, Mulrooney DA, Vogel RI, Solovey A, Hebbel R, Peterson BA, Neglia JP, Biewen C, Konety SH, Duprez DA.

Vasc Health Risk Manag. 2018 Sep 10;14:205-211. doi: 10.2147/VHRM.S151847. eCollection 2018.

16.

Patterns of Immunohistochemistry Utilization in Metastases to the Liver.

Amin K, El-Rayes D, Snover D, Mettler T, Vogel RI, Khalifa MA.

Appl Immunohistochem Mol Morphol. 2019 Jul;27(6):441-447. doi: 10.1097/PAI.0000000000000643.

PMID:
30192243
17.

A qualitative study of barriers to genetic counseling and potential for mobile technology education among women with ovarian cancer.

Vogel RI, Niendorf K, Lee H, Petzel S, Lee HY, Geller MA.

Hered Cancer Clin Pract. 2018 Jul 4;16:13. doi: 10.1186/s13053-018-0095-z. eCollection 2018.

18.

Chemotherapy-Induced Tunneling Nanotubes Mediate Intercellular Drug Efflux in Pancreatic Cancer.

Desir S, O'Hare P, Vogel RI, Sperduto W, Sarkari A, Dickson EL, Wong P, Nelson AC, Fong Y, Steer CJ, Subramanian S, Lou E.

Sci Rep. 2018 Jun 21;8(1):9484. doi: 10.1038/s41598-018-27649-x.

19.

Effect of intra-operative glove changing during cesarean section on post-operative complications: a randomized controlled trial.

Scrafford JD, Reddy B, Rivard C, Vogel RI.

Arch Gynecol Obstet. 2018 Jun;297(6):1449-1454. doi: 10.1007/s00404-018-4748-y. Epub 2018 Mar 19.

20.

A pilot investigation on impact of participation in a long-term follow-up clinic (LTFU) on breast cancer and cardiovascular screening among women who received chest radiation for Hodgkin lymphoma.

Baxstrom K, Peterson BA, Lee C, Vogel RI, Blaes AH.

Support Care Cancer. 2018 Jul;26(7):2361-2368. doi: 10.1007/s00520-018-4072-x. Epub 2018 Feb 7.

21.

Assessment of Circulating Tumor Cells as a Predictive Biomarker of Histology in Women With Suspected Ovarian Cancer.

Lou E, Vogel RI, Teoh D, Hoostal S, Grad A, Gerber M, Monu M, Lukaszewski T, Deshpande J, Linden MA, Geller MA.

Lab Med. 2018 Mar 21;49(2):134-139. doi: 10.1093/labmed/lmx084.

22.

A Cross-Sectional Review of Cervical Cancer Messages on Twitter During Cervical Cancer Awareness Month.

Teoh D, Shaikh R, Vogel RI, Zoellner T, Carson L, Kulasingam S, Lou E.

J Low Genit Tract Dis. 2018 Jan;22(1):8-12. doi: 10.1097/LGT.0000000000000363.

23.

Patterns of postpartum contraceptive use among Somali immigrant women living in Minnesota.

Millar A, Vogel RI, Bedell S, Ayers Looby M, Hubbs JL, Harlow BL, Ghebre R.

Contracept Reprod Med. 2017 Apr 4;2:14. doi: 10.1186/s40834-017-0041-x. eCollection 2017.

24.

Prophylactic Negative Pressure Wound Therapy in Obese Patients Following Cesarean Delivery.

Looby MA, Vogel RI, Bangdiwala A, Hyer B, Das K.

Surg Innov. 2018 Feb;25(1):43-49. doi: 10.1177/1553350617736652. Epub 2017 Nov 1.

PMID:
29090986
25.

A Qualitative Study of Quality of Life Concerns following a Melanoma Diagnosis.

Vogel RI, Strayer LG, Ahmed RL, Blaes A, Lazovich D.

J Skin Cancer. 2017;2017:2041872. doi: 10.1155/2017/2041872. Epub 2017 May 28.

26.

Assessment of the Intraoperative Consultation Service Rendered by General Pathologists in a Scenario Where a Well-Defined Decision Algorithm Is Followed.

Khalifa MA, Salama S, Vogel RI, Klein ME, Richter J, Pulver T, Mullany SA, Winterhoff B.

Am J Clin Pathol. 2017 Mar 1;147(3):322-326. doi: 10.1093/ajcp/aqw223.

27.

UNC-45A is required for neurite extension via controlling NMII activation.

Iizuka Y, Mooneyham A, Sieben A, Chen K, Maile M, Hellweg R, Schütz F, Teckle K, Starr T, Thayanithy V, Vogel RI, Lou E, Lee MK, Bazzaro M.

Mol Biol Cell. 2017 May 15;28(10):1337-1346. doi: 10.1091/mbc.E16-06-0381. Epub 2017 Mar 29.

28.

Sun Exposure and Protection Behaviors among Long-term Melanoma Survivors and Population Controls.

Vogel RI, Strayer LG, Engelman L, Nelson HH, Blaes AH, Anderson KE, Lazovich D.

Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):607-613. doi: 10.1158/1055-9965.EPI-16-0854. Epub 2017 Mar 2.

29.

Comparison of quality of life among long-term melanoma survivors and non-melanoma controls: a cross-sectional study.

Vogel RI, Strayer LG, Engelman L, Nelson HH, Blaes AH, Anderson KE, Lazovich D.

Qual Life Res. 2017 Jul;26(7):1761-1766. doi: 10.1007/s11136-017-1532-6. Epub 2017 Feb 27.

30.

CK2 Molecular Targeting-Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer.

Trembley JH, Kren BT, Abedin MJ, Vogel RI, Cannon CM, Unger GM, Ahmed K.

Pharmaceuticals (Basel). 2017 Feb 21;10(1). pii: E25. doi: 10.3390/ph10010025. Review.

31.

Enhanced Recovery Program and Length of Stay After Laparotomy on a Gynecologic Oncology Service: A Randomized Controlled Trial.

Dickson EL, Stockwell E, Geller MA, Vogel RI, Mullany SA, Ghebre R, Witherhoff BJ, Downs LS Jr, Carson LF, Teoh D, Glasgow M, Gerber M, Rivard C, Erickson BK, Hutchins J, Argenta PA.

Obstet Gynecol. 2017 Feb;129(2):355-362. doi: 10.1097/AOG.0000000000001838.

32.

Early elective delivery and vaginal birth after cesarean in rural US maternity hospitals.

Heinrich D, Vogel RI, Kozhimannil KB.

Rural Remote Health. 2016 Oct-Dec;16(4):3956. Epub 2016 Nov 15.

33.

Prognostic factors for survival in advanced appendiceal cancers.

Khan F, Vogel RI, Diep GK, Tuttle TM, Lou E.

Cancer Biomark. 2016;17(4):457-462. doi: 10.3233/CBM-160662.

34.

Evaluation of the American College of Surgeons National Surgical Quality Improvement Program Surgical Risk Calculator in Gynecologic Oncology Patients Undergoing Minimally Invasive Surgery.

Teoh D, Halloway RN, Heim J, Vogel RI, Rivard C.

J Minim Invasive Gynecol. 2017 Jan 1;24(1):48-54. doi: 10.1016/j.jmig.2016.10.005. Epub 2016 Oct 24.

35.

Abuse liability assessment of an e-cigarette refill liquid using intracranial self-stimulation and self-administration models in rats.

LeSage MG, Staley M, Muelken P, Smethells JR, Stepanov I, Vogel RI, Pentel PR, Harris AC.

Drug Alcohol Depend. 2016 Nov 1;168:76-88. doi: 10.1016/j.drugalcdep.2016.08.628. Epub 2016 Sep 1.

36.

Gender differences in snus versus nicotine gum for cigarette avoidance among a sample of US smokers.

Allen A, Vogel RI, Meier E, Anderson A, Jensen J, Severson HH, Hatsukami D.

Drug Alcohol Depend. 2016 Nov 1;168:8-12. doi: 10.1016/j.drugalcdep.2016.08.624. Epub 2016 Aug 28.

37.

The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.

Law EK, Sieuwerts AM, LaPara K, Leonard B, Starrett GJ, Molan AM, Temiz NA, Vogel RI, Meijer-van Gelder ME, Sweep FC, Span PN, Foekens JA, Martens JW, Yee D, Harris RS.

Sci Adv. 2016 Oct 7;2(10):e1601737. eCollection 2016 Oct.

38.

CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors.

Ahmed K, Kren BT, Abedin MJ, Vogel RI, Shaughnessy DP, Nacusi L, Korman VL, Li Y, Dehm SM, Zimmerman CL, Niehans GA, Unger GM, Trembley JH.

Oncotarget. 2016 Sep 20;7(38):61789-61805. doi: 10.18632/oncotarget.11442.

39.

Temozolomide treatment of pituitary carcinomas and atypical adenomas: systematic review of case reports.

Ji Y, Vogel RI, Lou E.

Neurooncol Pract. 2016 Sep;3(3):188-195. Epub 2015 Nov 12.

40.

Long term follow-up of a phase II trial of multimodal therapy given in a "sandwich" method for stage III, IV, and recurrent endometrial cancer.

Glasgow M, Vogel RI, Burgart J, Argenta P, Dusenbery K, Geller MA.

Gynecol Oncol Res Pract. 2016 May 26;3:6. doi: 10.1186/s40661-016-0027-4. eCollection 2016.

41.

Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer.

Rizzardi AE, Zhang X, Vogel RI, Kolb S, Geybels MS, Leung YK, Henriksen JC, Ho SM, Kwak J, Stanford JL, Schmechel SC.

Diagn Pathol. 2016 Jul 11;11(1):63. doi: 10.1186/s13000-016-0511-5.

42.

A model for patient-direct screening and referral for familial cancer risk.

Niendorf KB, Geller MA, Vogel RI, Church TR, Leininger A, Bakke A, Madoff RD.

Fam Cancer. 2016 Oct;15(4):707-16. doi: 10.1007/s10689-016-9912-6.

43.

Tunneling nanotube formation is stimulated by hypoxia in ovarian cancer cells.

Desir S, Dickson EL, Vogel RI, Thayanithy V, Wong P, Teoh D, Geller MA, Steer CJ, Subramanian S, Lou E.

Oncotarget. 2016 Jul 12;7(28):43150-43161. doi: 10.18632/oncotarget.9504.

44.

USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment.

Vogel RI, Pulver T, Heilmann W, Mooneyham A, Mullany S, Zhao X, Shahi M, Richter J, Klein M, Chen L, Ding R, Konecny G, Kommoss S, Winterhoff B, Ghebre R, Bazzaro M.

Oncotarget. 2016 May 24;7(21):30962-76. doi: 10.18632/oncotarget.8821.

45.

Designing an Educational Website to Improve Quality of Supportive Oncology Care for Women with Ovarian Cancer: An Expert Usability Review and Analysis.

McClellan MA, Karumur RP, Vogel RI, Petzel SV, Cragg J, Chan D, Jacko JA, Sainfort F, Geller MA.

Int J Hum Comput Interact. 2016;32(4):297-307. Epub 2016 Jan 11.

46.

Predictors of Adherence to Nicotine Replacement Therapy (Nicotine Patch) Among Homeless Persons Enrolled in a Randomized Controlled Trial Targeting Smoking Cessation.

Ojo-Fati O, Thomas JL, Vogel RI, Ogedegbe O, Jean-Louis G, Okuyemi KS.

J Fam Med. 2016;3(7). pii: 1079. Epub 2016 Sep 6.

47.

Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer.

Hermanson DL, Bendzick L, Pribyl L, McCullar V, Vogel RI, Miller JS, Geller MA, Kaufman DS.

Stem Cells. 2016 Jan;34(1):93-101. doi: 10.1002/stem.2230. Epub 2015 Dec 6.

48.

Antibiotic Use after Free Tissue Reconstruction of Head and Neck Defects: Short Course vs. Long Course.

Khariwala SS, Le B, Pierce BH, Vogel RI, Chipman JG.

Surg Infect (Larchmt). 2016 Feb;17(1):100-5. doi: 10.1089/sur.2015.131. Epub 2015 Oct 26.

49.

Bile Acid Determination after Standardized Glucose Load in Pregnant Women.

Adams A, Jacobs K, Vogel RI, Lupo V.

AJP Rep. 2015 Oct;5(2):e168-71. doi: 10.1055/s-0035-1555128. Epub 2015 Jun 19.

50.

Perceived Health Risks of Snus and Medicinal Nicotine Products.

Hatsukami DK, Vogel RI, Severson HH, Jensen JA, O'Connor RJ.

Nicotine Tob Res. 2016 May;18(5):794-800. doi: 10.1093/ntr/ntv200. Epub 2015 Sep 18.

Supplemental Content

Loading ...
Support Center